Xu, Rong

COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States

Wang, Q. Q., Kaelber, D. C., Xu, R., & Volkow, N. D. (2021) · Molecular Psychiatry

COVID-19 Clinical Research StudiesOpioid Use Disorder Treatment

Cited by 634

Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes

Wang, L., Xu, R., Kaelber, D. C., & Berger, N. A. (2024) · JAMA Network Open

Metabolism, Diabetes, and CancerDiabetes Treatment and Management

Cited by 304

COVID‐19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US

Wang, Q., Davis, P. B., Gurney, M. E., & Xu, R. (2021) · Alzheimer's & Dementia

COVID-19 Clinical Research StudiesDementia and Cognitive Impairment Research

Cited by 257

Association of semaglutide with risk of suicidal ideation in a real-world cohort

Wang, W., Volkow, N. D., Berger, N. A., Davis, P. B., Kaelber, D. C., & Xu, R. (2024) · Nature Medicine

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 248

Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer’s disease

Zhang, X., Wang, R., Hu, D., Sun, X., Fujioka, H., Lundberg, K., Chan, E. R., Wang, Q., Xu, R., Flanagan, M. E., et al. (2020) · Science Advances

Inflammasome and immune disordersAlzheimer's disease research and treatments

Cited by 200

A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat

Xu, R., Wang, Q., & Li, L. (2015) · BMC Genomics

Gut microbiota and healthBioinformatics and Genomic Networks

Cited by 193

Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US

Wang, W., Wang, Q., Qi, X., Gurney, M., Perry, G., Volkow, N. D., Davis, P. B., Kaelber, D. C., & Xu, R. (2024) · Alzheimer's & Dementia

Diabetes Treatment and ManagementDementia and Cognitive Impairment Research

Cited by 180

Association of COVID-19 with New-Onset Alzheimer’s Disease

Wang, L., Davis, P. B., Volkow, N. D., Berger, N. A., Kaelber, D. C., & Xu, R. (2022) · Journal of Alzheimer's Disease

Long-Term Effects of COVID-19Dementia and Cognitive Impairment Research

Cited by 178

Towards understanding brain-gut-microbiome connections in Alzheimer’s disease

Xu, R., & Wang, Q. (2016) · BMC Systems Biology

Alzheimer's disease research and treatmentsGut microbiota and health

Cited by 175

Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer’s disease in patients with rheumatoid arthritis and psoriasis

Zhou, M., Xu, R., Kaelber, D. C., & Gurney, M. E. (2020) · PLOS ONE

Rheumatoid Arthritis Research and TherapiesDementia and Cognitive Impairment Research

Cited by 157

Association of Semaglutide With Tobacco Use Disorder in Patients With Type 2 Diabetes: Target Trial Emulation Using Real-World Data

Wang, W., Volkow, N. D., Berger, N. A., Davis, P. B., Kaelber, D. C., & Xu, R. (2024) · Annals of Internal Medicine

Smoking Behavior and CessationDiabetes Treatment and Management

Cited by 72

Semaglutide and opioid overdose risk in patients with type 2 diabetes and opioid use disorder

Wang, W., Volkow, N. D., Wang, Q., Berger, N. A., Davis, P. B., Kaelber, D. C., & Xu, R. (2024) · JAMA Network Open

Opioid Use Disorder TreatmentDiabetes Treatment and Management

Cited by 63

Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data

Wang, L., Wang, Q., Li, L., Kaelber, D. C., & Xu, R. (2025) · JNCI: Journal of the National Cancer Institute

Diabetes Treatment and ManagementPancreatic and Hepatic Oncology Research

Cited by 53

Semaglutide or tirzepatide and optic nerve and visual pathway disorders in type 2 diabetes

Wang, L., Volkow, N. D., Kaelber, D. C., & Xu, R. (2025) · JAMA Network Open

Diabetes Treatment and ManagementDrug-Induced Ocular Toxicity

Cited by 51

Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis

Wang, Q., & Xu, R. (2019) · BMC Genomics

Gut microbiota and healthRheumatoid Arthritis Research and Therapies

Cited by 46

Mining comorbidities of opioid use disorder from FDA adverse event reporting system and patient electronic health records

Pan, Y., & Xu, R. (2022) · BMC Medical Informatics and Decision Making

Opioid Use Disorder TreatmentPharmacovigilance and Adverse Drug Reactions

Cited by 11